Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Across Multiple Cancers and the Ability to Quantify ER Pathway Activation in Breast Cancer from a Simple Blood Test
June 02, 2024 10:00 ET
|
Precede Biosciences, Inc.
HER2 status was accurately assessed in 172 patients with advanced breast, gastroesophageal, and ovarian cancersER status was accurately assessed and the level of ER pathway activation quantified in 87...
Liquid Biopsy Market is Expected to Reach $11.3 billion | MarketsandMarkets™
May 27, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 27, 2024 (GLOBE NEWSWIRE) -- Liquid Biopsy market in terms of revenue was estimated to be worth $6.4 billion in 2024 and is poised to reach $11.3 billion by 2029, growing at a CAGR of...
Global Liquid Biopsy Market Report 2024: Early Cancer Screening Segment Accounted for the Highest Growth Rate in the Liquid Biopsy market, by Clinical Application
May 27, 2024 03:10 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (CTC, ctDNA, cfDNA), Technology (NGS, PCR), Application...
Global EV-Based Liquid Biopsy Industry Research 2024: Market Size, Share, Trends, Opportunities, and Forecasts, 2019-2029F
May 08, 2024 09:12 ET
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "EV-Based Liquid Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Circulating Tumor Cell (CTC) Market Forecast to Reach $26.1 Billion by 2032: Key Global and Regional Insights by Technology, Application, Product, Specimen, and End User
May 08, 2024 05:48 ET
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2024-2032" report has been added to ...
Global Exosome Research Market Outlook 2024-2028: Escalating Interest in Exosome-based Therapeutics
May 07, 2024 12:54 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Global Exosome Research Market by Product & Service (Kits, Reagents (Antibodies, Isolation Purification), Instruments), Indication (Cancer,...
Cancer Biomarkers Market Trends and Global Forecasts, 2024-2035 - Increase in Article Publications Reflect the Rising Interest of Companies in Novel Cancer Biomarkers
May 03, 2024 08:03 ET
|
Research and Markets
Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "Cancer Biomarkers Market: Industry Trends and Global Forecasts 2024-2035: Distribution by Type of Biomarker, Type of Cancer and Key Geographical...
United States Liquid Biopsy Market Analysis Report 2024: A $3.68 Billion Industry by 2032 from $1.06 Billion in 2023 - Emphasis on Companion Diagnostics, Increasing acceptance of Non-invasive Techniques
April 19, 2024 04:27 ET
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "United States Liquid Biopsy Market Report by Cancer types, Products, Application, Biomarkers, Sample types, End-Users, and Company Analysis 2024-2032"...
United States In-Vitro Diagnostics Insights Report 2024: Market to Reach $44.95 Billion by 2029 with Abbott, Diasorin, Biomerieux, Danaher, Bio-Rad, and Siemens Healthinees Dominating
April 10, 2024 10:12 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. In-Vitro...
Global Circulating Tumor Cells Market Projected to Reach USD 27.55 Billion by 2030, Driving Advancements in Cancer Management
March 29, 2024 05:37 ET
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Global Circulating Tumor Cells Market Size, Share & Trends Analysis Report by Application (Clinical/Liquid Biopsy, Research), Specimen (Bone...